Lawrence F. Levin, MD
Cardiology and Internal Medicine Physician
About Dr. Levin
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Chief of Cardiology, Hospital for Special Surgery
Clinical Associate Professor of Medicine, Weill Cornell Medical College
Affiliations
Fellow, American College of Cardiology
Certifications
ABIM Cardiology, 2000, 2010
ABIM Internal Medicine, 1997
Certification Board of Nuclear Cardiology, 2000, 2010
National Board of Echocardiography, 2000, 2010
Education
Cornell University Medical College, 1994Internship: NewYork-Presbyterian Hospital, 1994-1995
Residency: NewYork-Presbyterian Hospital, 1995-1997
Fellowship: NewYork-Presbyterian Hospital, 1997-2000
State Licensure
New York
Languages
EnglishFor My Patients
Publications by Dr. Levin
Patient Education
Selected Journal Articles
Research
Non-invasive cardiac imaging
Risk stratification for adverse cardiac events
Management of structural and ischemic heart disease
Clinical Trials / Research Studies
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of January 22, 2024, Dr. Levin reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.